The news. The narrative. The timeline.
Seventeen trials, 20,342 patients, no clinically meaningful benefit and a brain-bleed signal — the same week Health Canada cleared Lilly's Kisunla for early Alzheimer's.
23 calves — the best North Atlantic right whale season since 2009 — and 13 of 20 returning moms last calved in 2021 or 2022, a fertility-window healing.
Novo's Wegovy pill hits 113,000 weekly prescriptions in four months while Lilly's Foundayo rolls out modestly in its first, ahead of Novo's Wednesday Q1 print and TrumpRx live.
A 100,000-person Lancet Psychiatry cohort links GLP-1 use to 44% lower depression and 38% lower anxiety risk — a stealth psychiatric class hitting 100M+ Americans without labeling.
A midweek Cinco de Mayo compresses the household cycle into a fast dinner while Sheinbaum's holiday sits over a two-day Sinaloa interim governor.
Pineland Road Fire holds at 32,575 acres and 44 percent containment on Day 16 — fire behavior remains 'resistant to control' against a 40,000-acre threshold.
Utah confirms 625 measles cases — 428 from 2026, 197 from 2025 — inside a national 1,814-case total as PAHO's November elimination-status review keeps running.
Idaho's dairy outbreak still has no named vector and USDA has now formally dropped pre-movement H5N1 testing for cattle leaving unaffected states.
A peer-reviewed Science study now measures what the medical societies have been saying — the CDC's revised autism page is depressing vaccinations and confidence in the agency itself.
Three thousand radiologists head into the meeting's last full day in Washington with helium prices doubled, the federal reserve sold, and no policy answer in the room.
A 440-woman cohort finds aged white blood cells track the cognitive symptoms of major depression — hopelessness and anhedonia, not fatigue.
South African chemists found seventy-nine phenolic compounds in cannabis leaves — including the first-ever flavoalkaloids in the plant — most of them in the trim that growers throw out.